Flexible Pharma Automation: Tailored Solutions Based on Proven Platforms

Expert interview

Smaller batch sizes, increasing product diversity and more frequent changeovers are reshaping pharmaceutical manufacturing. How can pharmaceutical companies achieve flexible automation without developing every new machine from scratch?

In an expert interview published in Future of Healthcare, a special edition of the Swiss business publication Finanz und Wirtschaft, Raphael Huber, CEO of RoboMat AG, explains how tailored automation solutions can be combined with proven technology.

Tailored Machines, Not Prototypes

Pharmaceutical manufacturers need equipment tailored to their products and processes. At the same time, they expect reliable performance, short commissioning times and a smooth production ramp-up.

RoboMat therefore builds on proven machine platforms that can be adapted to specific customer requirements. This approach supports different product formats and production volumes without having to develop an entirely new machine for every application.

Flexibility as a Key Success Factor

The interview explores the growing importance of High Mix, Low Volume (HMLV) manufacturing, fast format changeovers and why machine speed alone is no longer sufficient to evaluate production efficiency.

Using practical examples from autoinjector labeling and tray handling, RoboMat demonstrates how flexible automation solutions support the cost-effective production of different product formats.

The full interview, “Our Customers Want a Tailored Machine, Not a Prototype”, was published in German in the Future of Healthcare special edition on October 28, 2026.

[Read the english translation (PDF)]